Migraine sufferers stigmatized because of their condition: study

January 17, 2013 by Steven Reinberg, Healthday Reporter
Migraine sufferers stigmatized because of their condition: study
Those around them don't take their attacks seriously, consider them unreliable, expert says.

(HealthDay)—People who suffer from frequent migraines are stigmatized in much the same way as people with epilepsy are, new research suggests.

"This study is providing evidence for what we all sort of knew was the case," said Dr. Noah Rosen, director of the Headache Center at the Cushing Neuroscience Institute at North Shore-LIJ Health System, in Manhasset, N.Y. He was not involved in the research.

Not only are migraine patients stigmatized, but so is the condition itself in terms of getting research money, Rosen noted. "It's not getting the recognition it really should, given the prevalence and disability associated with it," he said.

Migraine pain and symptoms affect 29.5 million Americans, according to the U.S. Department of Health and Human Services.

Rosen believes that because migraine—which causes a combination of severe headache, nausea, and other factors—affects patients' work and social lives, the people around them stigmatize them as unreliable.

"Migraine is a disease morbidity, not mortality," Rosen said. "That's why it doesn't get the respect that it really requires."

Moreover, people who can't feel the pain a migraine sufferer is going through can't appreciate how debilitating it can be, Rosen added.

Rosen believes that family and coworkers of people with migraine need to be educated about the condition. In addition, workplaces may need to be altered to remove things that can trigger a migraine, he suggested.

These triggers include stress and poor environmental conditions, which can be changed to reduce the likelihood of setting off a migraine, Rosen explained.

In a statement from the Thomas Jefferson University Hospital's Headache Center in Philadelphia, study author and Dr. William Young, said: "I don't think people realize that it is not unusual for people with migraine to have severe headaches every day—to be so disabled that they are unable to work. This is what causes the stigma—the fact that people with severe migraine may not be able to work."

And, Young added, "When people treat my patients as if they are to blame because they have a severe, debilitating disease, they are contributing to the problem and making life harder for them."

The study, by Young and colleagues at Thomas Jefferson and Rutgers University, was published online Jan. 16 in the journal PloS One.

To see how people with migraine were treated, Young's team collected data on 123 people with episodic migraine (defined as 14 or fewer headaches per month), 123 people with (more than 14 headaches per month with eight meeting the criteria for migraine), and 62 people with epilepsy. To evaluate these participants, the researchers used a so-called stigma scale for chronic illness.

Epilepsy patients were chosen for comparison because their condition, which can cause seizures, is known to carry a stigma for many people, the researchers noted.

The investigators found that people with chronic migraine scored significantly higher on the stigma score (54) than those with episodic migraine (42) and even higher than those with epilepsy (45).

Adjusting the scores for other factors, Young and colleagues found the score roughly equal for people with epilepsy and chronic migraine, while the scores for those with episodic migraine were much lower.

People with chronic migraine tended to miss more days of work than those with epilepsy. Many with migraine need bed rest during the day of the migraine, which can occurr several times during the month, the researchers noted.

As Rosen pointed out, migraine is often considered "just a headache," not a major health problem.

In Young's clinic, however, 25 percent of migraine patients cannot hold a job because of the disease and many more suffer severe headaches almost every day, he pointed out. Severe depression and even suicidal thoughts are common among patients with chronic , he added.

Explore further: Drug doesn't help prevent migraine after all

More information: For more on migraine, visit the U.S. National Library of Medicine.

Related Stories

Drug doesn't help prevent migraine after all

February 11, 2008

Contrary to some reports, the epilepsy drug oxcarbazepine does not appear to prevent migraine, according to research published in the February 12, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.

Migraine increases risk of severe skin sensitivity and pain

April 21, 2008

People with migraine are more likely to experience exacerbated skin sensitivity or pain after non-painful daily activities such as rubbing one’s head, combing one’s hair and wearing necklaces or earrings, compared to ...

A primer on migraine headaches

February 16, 2010

Migraine headache affects many people and a number of different preventative strategies should be considered, states an article in CMAJ (Canadian Medical Association Journal). The article, a primer for physicians, outlines ...

Migraine in children may affect school performance

October 29, 2012

Children with migraine are more likely to have below average school performance than kids who do not have headaches, according to new research published in the October 30, 2012, print issue of Neurology, the medical journal ...

Recommended for you

Immune breakthrough: Unscratching poison ivy's rash

August 23, 2016

We all know that a brush with poison ivy leaves us with an itchy painful rash. Now, Monash University and Harvard researchers have discovered the molecular cause of this irritation. The finding brings us a step closer to ...

Zika infection may affect adult brain cells

August 18, 2016

Concerns over the Zika virus have focused on pregnant women due to mounting evidence that it causes brain abnormalities in developing fetuses. However, new research in mice from scientists at The Rockefeller University and ...

Monkeys with Sudan ebolavirus treated successfully

August 22, 2016

Scientists funded by the National Institutes of Health (NIH) have successfully treated monkeys several days after the animals were infected with Sudan ebolavirus (SUDV). The study is important, according to the researchers, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.